Debrisoquine. A five-year study of a new hypotensive agent.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000578:Amidines / Q000009:adverse effects / Q000627:therapeutic use*; D000959:Antihypertensive Agents; D002648:Child; D004361:Drug Tolerance; D005260:Female; D006801:Humans; D006974:Hypertension, Malignant / Q000188:drug therapy*; D007024:Hypotension, Orthostatic / Q000139:chemically induced; D007546:Isoquinolines / Q000009:adverse effects / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009451:Neuroeffector Junction / Q000187:drug effects; D009638:Norepinephrine / Q000037:antagonists & inhibitors
D000578:Amidines; D000959:Antihypertensive Agents; D007546:Isoquinolines; D009638:Norepinephrine